Company Overview of Immunex Corporation
As of July 15, 2002, Immunex Corporation was acquired by Amgen, Inc. Immunex Corporation researches, develops, manufacturers, and markets therapeutic products for the treatment of cancer, infectious diseases, and autoimmune disorders. It offers products, such as Enbrel that is used in the treatment of rheumatoid arthritis; Novantrone, which is used to treat acute nonlymphocytic leukemia and pain associated with prostate cancer; and Leukine for use in bone marrow transplant patients. The company has franchise operations. It has a strategic alliance with American Home Products. The company was founded in 1981 and is based in Seattle, Washington.
51 University Street
Seattle, WA 98101
Founded in 1981
Key Executives for Immunex Corporation
Immunex Corporation does not have any Key Executives recorded.
Similar Private Companies By Industry
|Advanced Microbotics Corp.||United States|
|Invivoscribe Technologies, Inc.||United States|
|Xcede Technologies, Inc.||United States|
|Vasculox, Inc.||United States|
|Elusys Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Immunex Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.